AbCellera Biologics Inc. Common Shares (ABCL) - Live Price

AbCellera Biologics Inc. Common Shares

AbCellera Biologics Inc. Common Shares (ABCL) represent an innovative and rapidly growing company in the biopharmaceutical industry. Founded in 2015, AbCellera is dedicated to the development and commercialization of novel biologics, focusing on treating severe autoimmune diseases, cancer, and other unmet medical needs. The company's shares are traded on major stock exchanges, providing investors with a opportunity to participate in its impressive growth trajectory. As a leading player in the sector, AbCellera's success is closely tied to its strong research and development capabilities, strategic partnerships, and a commitment to improving the lives of patients worldwide. In this introduction, we have provided a brief overview of AbCellera's business, its growth potential, and the opportunities for investors in the dynamic biopharmaceutical sector.

Get AbCellera Biologics Inc. Common Shares Price Change Alerts

Verdasi can notify you when ABCL goes up or down. Get a text message or email when AbCellera Biologics Inc. Common Shares changes in price.

How are AbCellera Biologics Inc. Common Shares divided?

Approximately 36.75% of AbCellera Biologics Inc. Common Shares are owned by individual stakeholders. Mutual Funds actively invest in , controlling roughly 3.11% of all AbCellera Biologics Inc. Common Shares.

• Individual Stakeholders: 36.75%
• Mutual Fund: 3.11%
• Other Institutions: 0.00%

How much is AbCellera Biologics Inc. Common Shares stock worth?

AbCellera Biologics Inc. Common Shares (ABCL) is worth $6.54 USD as of November 21, 2024, 10:00 am UTC time.
View the interactive graph to see how much AbCellera Biologics Inc. Common Shares has changed in the last hour or historically.